Evolution of the Average Target: Lonza Group AG

Evolution of the Target Price: Lonza Group AG

Changes in Analyst Recommendations: Lonza Group AG

4324553edb9401b.Tq8ZPq2YSQbPaKLzMc4dQ26CNysutzimDOauG02TlRI.IeFIX-XeeEW6XMbebv1OehT3WmNh40zwS8vUaQnQxCsk1VsO2q99c58p9w~61b9f6fe4c336ea83532ba035fe746de
25/11 Morgan Stanley Upgrades Lonza Group to Overweight, Lifts PT MT
23/25/23 LONZA GROUP : Strong Q3 performance commentary aligns with full-year goals Alphavalue
28/25/28 AlphaValue/Baader Europe Upgrades Lonza Group on FY25 Guidance Lift, Robust Business Momentum MT
28/25/28 Swiss stocks - Factors to watch on July 28 RE
25/25/25 LONZA GROUP : Recognising the strength of the CDMO business Alphavalue
24/25/24 BofA Keeps Lonza Group at Buy After 'Very Strong' H1 MT
24/25/24 Swiss stocks - Factors to watch on July 24 RE
23/25/23 LONZA GROUP : H1 beat and full-year guidance upgrade impress the markets Alphavalue
09/25/09 LONZA GROUP : Stronger profitability due to positive mid-term customer demand Alphavalue
12/25/12 AlphaValue/Baader Europe Remains Upbeat on Lonza, Reassesses Financial Estimates MT
12/25/12 LONZA GROUP : Strong Confidence for 2025 Alphavalue
09/25/09 Swiss stocks - Factors to watch on May 9 RE
01/25/01 Swiss Market Index Recovers; Galderma Group Shares Rise MT
04/25/04 RBC Lifts Lonza Group's Price Target Amid Higher Earnings Expectations MT
26/25/26 LONZA GROUP : The Vacaville effect becomes more impactful Alphavalue
12/25/12 Morgan Stanley Downgrades Lonza Group to Equalweight, Lifts PT MT
04/25/04 Barclays Lifts Lonza Group's Price Target on Strong Growth, 'Achievable' Guidance MT
31/25/31 Berenberg Says Lonza 'Back to Form' After FY24 Earnings Update MT
30/25/30 LONZA GROUP : A solid finish by hitting the profitability target – on the spot Alphavalue
16/24/16 Stifel Upgrades Lonza Group to Buy, Raises PT MT
12/24/12 LONZA GROUP : Preparing for the next growth momentum Alphavalue
30/24/30 LONZA GROUP : EPS upgrade (2024: +2.7%, 2025: +2.9%) Alphavalue
25/24/25 LONZA GROUP : Cost-cutting measures may drive profitability in the H2 Alphavalue
19/24/19 LONZA : Stifel raises its target price Zonebourse
12/24/12 LONZA GROUP : Vacaville acquisition drives Biologics’ future Alphavalue
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+24.68%
+11.11%
+20.91%
+13.89%
-13.28%
-9.4%
-3.56%
Average +6.34%
Weighted average by Cap. +11.08%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
557.40CHF
Average target price
677.74CHF
Spread / Average Target
+21.59%
High Price Target
815.00CHF
Spread / Highest target
+46.21%
Low Price Target
550.00CHF
Spread / Lowest Target
-1.33%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
alphavalue Anas Patel
Stifel Nicolaus
Berenberg Bank
Deutsche Bank Securities
Jefferies & Co.
Equita
Societe Generale
Research Capital
Octagon Capital
Bernstein
RBC Capital Markets
International Strategy & Investment Group
HSBC
Credit Suisse
Mirae Asset Group
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
557.40CHF
Average target price
677.74CHF
Spread / Average Target
+21.59%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LONN Stock
  4. Consensus Lonza Group AG